• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨化三醇疗法及患者教育计划对甲状旁腺功能亢进症的临床疗效

Clinical outcome of calcitriol therapy and patient education program on hyperparathyroidism.

作者信息

Poole R, Bell N, Diab A

机构信息

Gambro Healthcare, Orangeburg, SC 29118, USA.

出版信息

J Ren Nutr. 1999 Apr;9(2):95-8. doi: 10.1016/s1051-2276(99)90007-9.

DOI:10.1016/s1051-2276(99)90007-9
PMID:10089266
Abstract

The treatment of patients with hyperparathyroidism provides a challenge for the dialysis team. Interventions with calcitriol therapy, phosphate binders, motivational efforts, and education on diet and renal osteodystrophy can help to control parathyroid hormone (PTH). Effects of intervention were studied on 54 hemodialysis patients for 1 year, resulting in improved outcomes.

摘要

甲状旁腺功能亢进患者的治疗给透析团队带来了挑战。使用骨化三醇疗法、磷结合剂、激励措施以及关于饮食和肾性骨营养不良的教育等干预措施有助于控制甲状旁腺激素(PTH)。对54名血液透析患者进行了为期1年的干预效果研究,结果改善了治疗结果。

相似文献

1
Clinical outcome of calcitriol therapy and patient education program on hyperparathyroidism.骨化三醇疗法及患者教育计划对甲状旁腺功能亢进症的临床疗效
J Ren Nutr. 1999 Apr;9(2):95-8. doi: 10.1016/s1051-2276(99)90007-9.
2
Effectiveness of intravenous and subcutaneous calcitriol in the treatment of secondary hyperparathyroidism.静脉注射和皮下注射骨化三醇治疗继发性甲状旁腺功能亢进的疗效
Nephron. 1998 Sep;80(1):119-20. doi: 10.1159/000045153.
3
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
4
The effect of calcitriol on renal anaemia in patients undergoing long-term dialysis.骨化三醇对长期透析患者肾性贫血的影响。
Int Urol Nephrol. 1997;29(1):119-27. doi: 10.1007/BF02551427.
5
Management of secondary hyperparathyroidism: the gap between diagnosis and treatment. The Renal Osteodystrophy Multicenter Enquiry.
Am J Med Sci. 2000 Aug;320(2):107-11. doi: 10.1097/00000441-200008000-00008.
6
Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism.静脉注射骨化三醇疗法对继发性甲状旁腺功能亢进控制的长期影响。
Am J Kidney Dis. 1996 Nov;28(5):704-12. doi: 10.1016/s0272-6386(96)90252-8.
7
Comparison of the Pharmacological Effects of Paricalcitol Versus Calcitriol on Secondary Hyperparathyroidism in the Dialysis Population.帕立骨化醇与骨化三醇对透析人群继发性甲状旁腺功能亢进药理作用的比较。
Ther Apher Dial. 2016 Jun;20(3):261-6. doi: 10.1111/1744-9987.12434.
8
Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient.甲状旁腺功能作为血液透析患者对骨化三醇治疗反应的一个决定因素。
Kidney Int. 1999 Jul;56(1):306-17. doi: 10.1046/j.1523-1755.1999.00538.x.
9
Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients.骨化三醇和西那卡塞联合治疗血液透析患者重度继发性甲状旁腺功能亢进时,胆钙化醇可进一步降低甲状旁腺激素水平。
Nutrients. 2018 Feb 10;10(2):196. doi: 10.3390/nu10020196.
10
Safety and efficacy of long-term treatment of secondary hyperparathyroidism by low-dose intravenous calcitriol.低剂量静脉注射骨化三醇长期治疗继发性甲状旁腺功能亢进的安全性和有效性。
Am J Kidney Dis. 1992 Jun;19(6):532-9. doi: 10.1016/s0272-6386(12)80831-6.